U.S. Markets closed
  • S&P 500

    4,387.16
    -8.10 (-0.18%)
     
  • Dow 30

    34,838.16
    -97.31 (-0.28%)
     
  • Nasdaq

    14,681.07
    +8.39 (+0.06%)
     
  • Russell 2000

    2,215.50
    -10.75 (-0.48%)
     
  • Crude Oil

    71.49
    +0.23 (+0.32%)
     
  • Gold

    1,816.00
    -6.20 (-0.34%)
     
  • Silver

    25.45
    -0.12 (-0.49%)
     
  • EUR/USD

    1.1876
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.1740
    -0.0650 (-5.25%)
     
  • Vix

    19.46
    +1.22 (+6.69%)
     
  • GBP/USD

    1.3890
    +0.0007 (+0.0486%)
     
  • USD/JPY

    109.3250
    +0.0160 (+0.0146%)
     
  • BTC-USD

    39,423.98
    -876.02 (-2.17%)
     
  • CMC Crypto 200

    951.68
    -9.21 (-0.96%)
     
  • FTSE 100

    7,081.72
    +49.42 (+0.70%)
     
  • Nikkei 225

    27,781.02
    +497.43 (+1.82%)
     

Pfizer Covid-19 Vaccine Could See Blockbuster Sales for Years

·2 min read
Pfizer Covid-19 Vaccine Could See Blockbuster Sales for Years
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

RBC Capital Markets analyst Daniel Busby says Pfizer's Covid-19 vaccine could see sales of $34 billion this year. The high efficacy and large market share of the Pfizer vaccine make it resilient should a global surplus of vaccines arise.